Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN Grade-II, to Reduce Symptoms and to Improve the Quality of Life of Patients With CIPN

Clinical trial NCT06186479 · RECRUITING

Trial details

NCT number: NCT06186479
Sponsor: WALA Heilmittel GmbH
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Chemotherapy-induced Polyneuropathy

Start date: 2024-03-13
Primary completion: 2027-08-01
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.